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Performing measurements at the ultra-trace level is a challenging task.  Fortunately, in most cases, 
today’s analytical tools offer the required sensitivity to detect below the ppt level with good 
reproducibility.  To maintain such instrumental LODs (iLODs) while considering complex matrices like 
human serum, it is mandatory to implement a pre-measurement sample preparation protocol that often 
consists in a time and resource consuming multi-step procedure.  This scenario often results in lengthy 
processes and very complex analytical QA/QC procedures that are undesirable in large scale 
epidemiological studies. 
A group of 17 2,3,7,8-substituted dioxins (polychlorinated dibenzo-p-dioxins (PCDDs) and 
polychlorinated dibenzofurans (PCDFs)) and 18 selected PCBs (polychlorinated biphenyls) (ntot analytes 
= 35) are usually targeted in epidemiological studies.  Their measurement permits to describe the 
contamination profile of the specimen and estimate the dioxin-related toxicity in terms of toxic 
equivalents (TEQs).  Because the bio-accumulation of those analytes occurs mainly through the lipid 
compartment, blood (serum) is commonly the matrix of choice to monitor dioxin levels in humans 
because of the relatively non-invasive collection of samples, compared to adipose tissue and organ 
collection. 
In the present report, the validation and the routine use of a rapid high throughput multi-step 
analytical method for the measurement of selected dioxins and PCBs is presented.  The extraction of 20ml 
human serum samples is based on the use of 2g/15ml endcapped (-Si(Me3)) octadecyl solid phase 
extraction (SPE) disposable cartridges.  The clean-up and fractionation in sub-groups of analytes is 
performed by automated multi-sorbent liquid chromatography (LC).  The congener separation and 
concentration measurement is carried out by gas chromatography (GC) coupled to C
13
-based isotope 
dilution (ID) high resolution mass spectrometry (HRMS) using a sector instrument. 
Series of 20 samples (1 blank (BC), 1 quality control sample (QC), 18 unknown samples) are 
processed in batches.  Extractions are carried out by a single operator on 2 separate manifolds to facilitate 
flow control. Sodium sulfate disposable cartridges (2.5g) are placed between the SPE cartridge and the 
collection tube after vacuum drying (25 min) and prior hexane elution (3 x 5ml).  This ensures the 
complete removal of undesirable water prior to clean-up.  The total extraction time is 4h for 20 samples.  
For clean-up, 6g multi-layer silica (acidic, basic, neutral), 6g basic alumina, and carbon (0.3g) dispersed 
on Celite (2g) disposable columns are used with the automated system (Power-Prep, FMS Inc., Boston, 
MA, USA).  A first fraction (120ml of hexane-dichloromethane 1:1) containing mono-ortho-PCBs (MO-
PCBs) and indicator PCBs (I-PCBs) is collected after 45 min.  A second fraction (75ml of toluene) 
containing PCDDs, PCDFs, and non-ortho PCBs (NO-PCBs) is collected after 55 min.  The entire run 
time is 75 min, including column removal and system decontamination.  Solvent volumes of those 2 
fractions are reduced to 500µl using an automated sensor-equipped evaporation device (TurbovapII, 
Caliper Life Sciences, Teralfene, Belgium).  Nonane is added as keeper (90µl and 5µl for fraction 1 and 2, 
respectively).  Remaining volumes of hexane-dichloromethane and toluene are further removed under 
slight vacuum at controlled temperature using another automated device (RapidVap, Labconco, Kansas 
City, MS, USA). Lipid content determinations are carried out enzymatically on sub-samples. The total 
concentration time is 2h for fraction 1 and 3h for fraction 2.  Congener separation and measurement is 
performed during 2 separate GC-IDHRMS runs (one per fraction).  Fraction 1 run time is 30min although 
fraction 2 analysis requires 1h.  Measurements are performed automatically overnight and systematic 
daily system maintenance is carried out by the operator after each series. 
 
The entire procedure is ISO 17025 and in agreement with EU QA/QC recommendations [1] regarding 
blank controls, sensitivity, LODs, LOQs, trueness, precision and interlaboratory studies.  QC charts based 
on ‘in-house’ fortified bovine serum QC pool show random distribution of data points over time and 
operators, with all data included on a 95% confidence interval.  In terms of turnover, once series keep 
being extracted, analytical results of 20 samples are reported every day, averaging the complete 
measurement of 100 samples (35 analytes per samples) per week.  The cost per sample based on 3000 
samples per year for 5 years, including instrumentation paying-off and maintenance, all ID standards, 
lipid determinations, and employment is estimated to be 550 EUR. 
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